Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Elanco Animal Health (ELAN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Elanco Animal Health's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
13.46 +0.32    +2.40%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
13.57
+0.11
+0.82%
0:02:36 - Real-time Data
  • Volume: 3,895,294
  • Bid/Ask: 12.76 / 16.50
  • Day's Range: 13.17 - 13.53
Type:  Equity
Market:  United States
Elanco Animal Health 13.46 +0.32 +2.40%

ELAN Balance Sheet

 
Assess the latest Elanco Animal Health balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced ELAN Annual Report data, financial summaries and charts are available for Elanco Animal Health investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 3407 3565 3652 3548
Cash and Short Term Investments 352 369 407 326
Cash - - - -
Cash & Equivalents 352 369 367 318
Short Term Investments - - - -
Total Receivables, Net 1159 1135 1225 1264
Accounts Receivables - Trade, Net 842 911 1000 1051
Total Inventory 1735 1690 1690 1596
Prepaid Expenses 96 307 330 334
Other Current Assets, Total 65 64 - 28
Total Assets 14362 14344 15796 15769
Property/Plant/Equipment, Total - Net 1166 992 1007 1000
Property/Plant/Equipment, Total - Gross 1981 - - 1744
Accumulated Depreciation, Total -815 - - -744
Goodwill, Net 5094 4902 6040 6061
Intangibles, Net 4494 4475 4678 4791
Long Term Investments 26 68 87 36
Note Receivable - Long Term 317 224 225 213
Other Long Term Assets, Total 175 342 332 333
Other Assets, Total 641 619 505 368
Total Current Liabilities 1241 1265 1284 1578
Accounts Payable 270 296 354 381
Payable/Accrued - - - -
Accrued Expenses 525 356 332 439
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 70 39 39 381
Other Current liabilities, Total 376 574 559 377
Total Liabilities 8139 8210 8376 8289
Total Long Term Debt 5736 5870 6023 5648
Long Term Debt 5736 5870 6023 5648
Capital Lease Obligations - - - -
Deferred Income Tax 567 643 658 663
Minority Interest - - - -
Other Liabilities, Total -4154 -4329 -4363 -4386
Total Equity 6223 6134 7420 7480
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - - -
Additional Paid-In Capital 8777 8763 8752 8744
Retained Earnings (Accumulated Deficit) -2288 -2147 -1051 -954
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -266 -482 -281 -310
Total Liabilities & Shareholders' Equity 14362 14344 15796 15769
Total Common Shares Outstanding 492.85 492.68 492.55 492.42
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ELAN Price Commentary

Write your thoughts about Elanco Animal Health
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gurkan Ulusoy
Gurkan Ulusoy Nov 06, 2020 15:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Unless they prove the success of Bayer integration and report aggregated growth and profitability, investors will continue to approach with questions in mid term.
Reply
1 0
Report
Gurkan Ulusoy
Gurkan Ulusoy Nov 06, 2020 15:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Unless they prove the success of Bayer integration and report aggregated growth and profitability, investors will continue to approach with questions in mid term.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email